T-CELL LYMPHOMA
Clinical trials for T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat lymphoma? drug targets cancer even when marker is low
Disease control CompletedThis study tested a drug called brentuximab vedotin in 23 people with a rare type of T-cell lymphoma that had stopped responding to or returned after prior chemotherapy. The drug is designed to seek out and kill cancer cells that have a specific marker called CD30, even when leve…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Deepa Jagadeesh • Aim: Disease control
Last updated Apr 29, 2026 06:58 UTC
-
New treatment shows promise for rare skin lymphoma in chinese patients
Disease control CompletedThis study looked at the long-term side effects and effectiveness of a drug called brentuximab vedotin in 10 Chinese adults with a rare type of skin lymphoma (CD30-positive cutaneous T-cell lymphoma). Participants received the drug through a vein every 21 days for up to 16 cycles…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE4 • Sponsor: Takeda • Aim: Disease control
Last updated Apr 29, 2026 06:57 UTC